Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
Tepotinib for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
This trial will study the effects of tepotinib on patients with lung cancer that has spread to the brain. It will also look at tepotinib in combination with other drugs for patients who have developed resistance to their current treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.